Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) FCF Margin (2017 - 2025)

Catheter Precision has reported FCF Margin over the past 9 years, most recently at 636.97% for Q4 2025.

  • Quarterly FCF Margin rose 128517.0% to 636.97% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1015.51% through Dec 2025, up 120783.0% year-over-year, with the annual reading at 1015.51% for FY2025, 120783.0% up from the prior year.
  • FCF Margin was 636.97% for Q4 2025 at Catheter Precision, up from 965.93% in the prior quarter.
  • Over five years, FCF Margin peaked at 636.97% in Q4 2025 and troughed at 202450.0% in Q1 2021.
  • The 5-year median for FCF Margin is 2158.63% (2024), against an average of 39520.3%.
  • Year-over-year, FCF Margin plummeted -20193537bps in 2021 and then skyrocketed 11509021bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 110080.0% in 2021, then decreased by -9bps to 120160.0% in 2022, then skyrocketed by 99bps to 1489.84% in 2023, then dropped by -29bps to 1922.15% in 2024, then soared by 67bps to 636.97% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's FCF Margin are 636.97% (Q4 2025), 965.93% (Q3 2025), and 1090.09% (Q2 2025).